{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T10:48:46Z","timestamp":1740134926283,"version":"3.37.3"},"reference-count":9,"publisher":"American Society of Hematology","issue":"25","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,12,19]]},"DOI":"10.1182\/blood.2024026676","type":"journal-article","created":{"date-parts":[[2024,12,19]],"date-time":"2024-12-19T16:38:40Z","timestamp":1734626320000},"page":"2563-2564","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":0,"title":["Fishing for 1q gain is now open in amyloidosis"],"prefix":"10.1182","volume":"144","author":[{"given":"Ana\u00efs","family":"Schavgoulidze","sequence":"first","affiliation":[{"name":"University Hospital of Toulouse and INSERM"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1580-6106","authenticated-orcid":false,"given":"Jill","family":"Corre","sequence":"additional","affiliation":[{"name":"University Hospital of Toulouse and INSERM"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"234","reference":[{"issue":"25","key":"2024121916304456200_bib1","doi-asserted-by":"crossref","first-page":"2613","DOI":"10.1182\/blood.2024025899","article-title":"Prognostic impact of cytogenetic abnormalities detected by FISH in AL amyloidosis with daratumumab-based frontline therapy","volume":"144","author":"Chakraborty","year":"2024","journal-title":"Blood"},{"issue":"1","key":"2024121916304456200_bib2","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1056\/NEJMoa2028631","article-title":"Daratumumab-based treatment for immunoglobulin light-chain amyloidosis","volume":"385","author":"Kastritis","year":"2021","journal-title":"N\u00a0Engl J Med"},{"issue":"3","key":"2024121916304456200_bib3","doi-asserted-by":"crossref","first-page":"100953","DOI":"10.1016\/j.currproblcancer.2023.100953","article-title":"Daratumumab plus bortezomib and dexamethasone in newly diagnosed systemic light chain amyloidosis","volume":"47","author":"Kennedy","year":"2023","journal-title":"Curr Probl Cancer"},{"key":"2024121916304456200_bib4","doi-asserted-by":"crossref","first-page":"101040","DOI":"10.1016\/j.blre.2023.101040","article-title":"State-of-the-art review on AL amyloidosis in Western countries: epidemiology, health economics, risk assessment and therapeutic management of a rare disease","volume":"59","author":"Sabinot","year":"2023","journal-title":"Blood Rev"},{"issue":"6","key":"2024121916304456200_bib5","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1016\/j.mayocp.2021.03.012","article-title":"Treatment of AL amyloidosis: Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) consensus statement 2020 update","volume":"96","author":"Muchtar","year":"2021","journal-title":"Mayo Clin Proc"},{"issue":"12","key":"2024121916304456200_bib6","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1200\/JCO.2014.57.4947","article-title":"Translocation t(11;14) is associated with adverse outcome in patients with newly diagnosed AL amyloidosis when treated with bortezomib-based regimens","volume":"33","author":"Bochtler","year":"2015","journal-title":"J\u00a0Clin Oncol"},{"issue":"1","key":"2024121916304456200_bib7","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1002\/ajh.26399","article-title":"Predictive factors of outcomes in patients with AL amyloidosis treated with daratumumab","volume":"97","author":"Szalat","year":"2022","journal-title":"Am J Hematol"},{"issue":"5","key":"2024121916304456200_bib8","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1080\/14712598.2024.2357382","article-title":"Anti-CD38 monoclonal antibodies in multiple myeloma with gain\/amplification of chromosome arm 1q: a review of the literature","volume":"24","author":"Barbieri","year":"2024","journal-title":"Expert Opin Biol Ther"},{"issue":"9","key":"2024121916304456200_bib9","doi-asserted-by":"crossref","first-page":"e467","DOI":"10.1038\/bcj.2016.72","article-title":"A\u00a0DNA target-enrichment approach to detect mutations, copy number changes and immunoglobulin translocations in multiple myeloma","volume":"6","author":"Bolli","year":"2016","journal-title":"Blood Cancer J"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/blood\/article-pdf\/144\/25\/2563\/2347034\/blood_bld-2024-026676-c-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/blood\/article-pdf\/144\/25\/2563\/2347034\/blood_bld-2024-026676-c-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,19]],"date-time":"2024-12-19T16:38:44Z","timestamp":1734626324000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/144\/25\/2563\/534564\/Fishing-for-1q-gain-is-now-open-in-amyloidosis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,19]]},"references-count":9,"journal-issue":{"issue":"25","published-print":{"date-parts":[[2024,12,19]]}},"URL":"https:\/\/doi.org\/10.1182\/blood.2024026676","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"type":"print","value":"0006-4971"},{"type":"electronic","value":"1528-0020"}],"subject":[],"published":{"date-parts":[[2024,12,19]]}}}